Cargando…

Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study

PURPOSE: The present study was designed to compare the efficiency of the progestin-primed ovarian stimulation (PPOS) protocol with clomiphene citrate (CC) supplementation (PPOS+CC) and the standard PPOS protocol for women of different ages with diminished ovarian reserve (DOR). PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yue, Chen, Qianqian, Zhu, Jing, Teng, Yili, Huang, Xuefeng, Chen, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710074/ https://www.ncbi.nlm.nih.gov/pubmed/34992345 http://dx.doi.org/10.2147/DDDT.S338748

Ejemplares similares

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
por: Ye, Hongjuan, et al.
Publicado: (2018)

Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study
por: Liu, Ahui, et al.
Publicado: (2022)

Editorial: Recent advances in progestin-primed ovarian stimulation
por: Chen, Qiuju
Publicado: (2022)

Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
por: Yang, Ai-Min, et al.
Publicado: (2022)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
por: Huang, Haipeng, et al.
Publicado: (2022)

The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
por: Zhang, Junwei, et al.
Publicado: (2021)

Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
por: Li, Danjun, et al.
Publicado: (2022)

Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First In Vitro Fertilization Cycle: A Retrospective Cohort Study
por: Tu, Xiaoyu, et al.
Publicado: (2022)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study
por: Filippi, Francesca, et al.
Publicado: (2023)

A delayed ovulation of progestin-primed ovarian stimulation (PPOS) by downregulating the LHCGR/PGR pathway
por: Xie, Yating, et al.
Publicado: (2023)

Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
por: Wu, Shuxie, et al.
Publicado: (2023)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency
por: Kalafat, Erkan, et al.
Publicado: (2022)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Body Mass Index Showed No Impact on the Outcome of In Vitro Fertilization in Progestin-Primed Ovarian Stimulation Protocol
por: Yang, Zhe, et al.
Publicado: (2021)

Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
por: Huang, Jialyu, et al.
Publicado: (2019)

Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2023)

Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures
por: Shen, Xi, et al.
Publicado: (2020)

Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
por: Pai, Angel Hsin-Yu, et al.
Publicado: (2023)

Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study
por: Peng, Qian, et al.
Publicado: (2019)

Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis
por: Zhang, Junwei, et al.
Publicado: (2023)

Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
por: Wang, Ningling, et al.
Publicado: (2018)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials
por: Guan, Shaogen, et al.
Publicado: (2021)

Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study
por: Huang, Jialyu, et al.
Publicado: (2019)

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis
por: Du, Mingze, et al.
Publicado: (2021)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
por: Yang, Liu, et al.
Publicado: (2023)

A Higher Estradiol Rise After Dual Trigger in Progestin-Primed Ovarian Stimulation Is Associated With a Lower Oocyte and Mature Oocyte Yield in Normal Responders
por: Huang, Jialyu, et al.
Publicado: (2019)

Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Optimal Ovulation Trigger–Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching
por: Shen, Xi, et al.
Publicado: (2019)

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study
por: Du, Mingze, et al.
Publicado: (2023)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
por: Zhou, Ruiqiong, et al.
Publicado: (2023)

Comparison of Cumulative Live Birth Rates between Flexible and Conventional Progestin-Primed Ovarian Stimulation Protocol in Poor Ovarian Response Patients According to POSEIDON Criteria: A Cohort Study
por: Chen, Ying, et al.
Publicado: (2023)

Progestins: Pro-senescence therapy for ovarian cancer?
por: Oesterreich, Steffi, et al.
Publicado: (2013)

Metformin—clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
por: Ayaz, Aqueela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sh64o2o57oo086slmt8295gsvp